These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Zygomycetes and zygomycosis in the new era of antifungal therapies]. Torres-Narbona M; Guinea J; Muñoz P; Bouza E Rev Esp Quimioter; 2007 Dec; 20(4):375-86. PubMed ID: 18563211 [TBL] [Abstract][Full Text] [Related]
4. Changing epidemiology of an emerging infection: zygomycosis. Meis JF; Chakrabarti A Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():10-4. PubMed ID: 19754750 [TBL] [Abstract][Full Text] [Related]
5. Emerging importance of infections due to zygomycetes in organ transplant recipients. Sun HY; Singh N Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S115-8. PubMed ID: 19013334 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967 [TBL] [Abstract][Full Text] [Related]
12. Forty-one recent cases of invasive zygomycosis from a global clinical registry. Rüping MJ; Heinz WJ; Kindo AJ; Rickerts V; Lass-Flörl C; Beisel C; Herbrecht R; Roth Y; Silling G; Ullmann AJ; Borchert K; Egerer G; Maertens J; Maschmeyer G; Simon A; Wattad M; Fischer G; Vehreschild JJ; Cornely OA J Antimicrob Chemother; 2010 Feb; 65(2):296-302. PubMed ID: 20008047 [TBL] [Abstract][Full Text] [Related]
13. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients? Salavert M Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340 [TBL] [Abstract][Full Text] [Related]
14. Treatment of zygomycosis: current and new options. Rogers TR J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i35-40. PubMed ID: 18063603 [TBL] [Abstract][Full Text] [Related]
15. [Zygomycosis after hematogeneic stem cell transplantation--a current problem?]. Glöckner A; Cornely OA Med Klin (Munich); 2006 Sep; 101(9):724-9. PubMed ID: 16977397 [TBL] [Abstract][Full Text] [Related]
16. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. Kontoyiannis DP; Lionakis MS; Lewis RE; Chamilos G; Healy M; Perego C; Safdar A; Kantarjian H; Champlin R; Walsh TJ; Raad II J Infect Dis; 2005 Apr; 191(8):1350-60. PubMed ID: 15776383 [TBL] [Abstract][Full Text] [Related]
17. [Invasive zygomycosis: notably in diabetes mellitus and iron overload]. Kullberg BJ; van 't Wout JW Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2603-5. PubMed ID: 18161259 [TBL] [Abstract][Full Text] [Related]
18. Trends in zygomycosis in children. Prasad PA; Vaughan AM; Zaoutis TE Mycoses; 2012 Jul; 55(4):352-6. PubMed ID: 21981587 [TBL] [Abstract][Full Text] [Related]
19. Outbreaks of zygomycosis in hospitals. Antoniadou A Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():55-9. PubMed ID: 19754759 [TBL] [Abstract][Full Text] [Related]